Bill Gates has his thumb on the scale in the NY State HCQ test trials, University of Albany's School of Public Health is observing the drug's impact on the patients Okay, most of us are in agreement that the results of HCQ against CV are pretty incredible, around 99.6% at last check. Cuomo finally agreed to a HCQ study against CV. As many as 4,000 seriously ill coronavirus patients in New York are being treated with the anti-malarial drug hydroxychloroquine, state health officials say. President Trump has touted hydroxychloroquine as a potential life-saver, although there is no widespread scientific evidence to date showing it helps battle COVID-19. But Gov. Andrew Cuomo last month said health care providers in the state would be using the drug in combination with the antibiotic Zithromax, or azithromycin, for some last-ditch cases, based on potentially promising research. Great! The truth can be revealed! On queue, in steps Bill Gates ... NYU Langone Medical School is conducting a random trial with a $9.5 million grant from the Bill & Melinda Gates Foundation. The medical group starts out being skeptical ... Health officials are treading cautiously, saying they don’t anticipate hydroxychloroquine will be a “miracle drug” against the coronavirus — but the studies are worth the gamble. In terms of the NYU clinical trial regarding prevention, researchers are enrolling 2,000 adult volunteers at six sites. They are recruiting people who lack any COVID-19 symptoms but have been in close contact with others who have a confirmed or pending diagnosis. Hmm. Doesn't sound like a known group of last-ditch patients. So this trial is using the standard placebo sugar pill for some test subjects and HCQ for the rest, right? On a random basis, the trial participants will receive either hydroxychloroquine or a placebo pill — vitamin C — every day for two weeks. Each day during the 14-day period and then again on Day 28, the participants will swab their nasal passages and send the samples to researchers to detect potential COVID-19 infection. “If everything goes as planned, the eight-week trial could provide answers by summer on whether a preventive dose of the drug is safe and effective,’’ NYU Langone said in a release. Whut?! Not an inert pill but a megadose of vitamin C? It has been reported high doses of vitamin C are effective against CV but it has not reported success rates as high as HCQ nor cure the patient as quickly. We know vitamin C helps us get over colds and flu more quickly. Q: Why would a trial study consist of two groups where one gets the test medication and the control group gets something other than an inert placebo? To taint the HCQ reported results? To show HCQ is only ~25% more effective than taking vitamin C? To play with the statistical numbers in order to downplay the efficacy of HCQ? Gates has trillions at stake ... source - https://nypost.com/2020/04/05/ny-coronavirus-patients-being-treated-with-anti-malarial-drug/ additional - https://mobile.twitter.com/Perpetualmaniac/status/1249473904948764678 https://clinicaltrials.gov/ct2/show/record/NCT04328961?view=record